Association between serum lipid levels, osteoprotegerin and depressive symptomatology in psychotic disorders (Q88551429)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29721726%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

title

Association between serum lipid levels, osteoprotegerin and depressive symptomatology in psychotic disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29721726%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29721726%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

8

Ingrid Melle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29721726%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

7

Ole A Andreassen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29721726%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

6

Vidar M Steen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29721726%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

author name string

Ingrid Dieset

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29721726%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Nils Eiel Steen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29721726%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Ragni H Mørch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29721726%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Trude S Iversen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29721726%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

publication date

2 May 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29721726%20AND%20SRC:MED&resulttype=core&format=json

European Archives of Psychiatry and Clinical Neuroscience

25 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29721726%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

volume

269

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29721726%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

page(s)

795-802

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29721726%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29721726%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

25 March 2020

copyright license

start time

2 May 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

A depression rating scale for schizophrenics

1 reference

12 December 2020

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

12 December 2020

Specificity of the Calgary Depression Scale for schizophrenics.

1 reference

12 December 2020

Depression during the longitudinal course of schizophrenia

1 reference

12 December 2020

Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents

1 reference

12 December 2020

Causes of the excess mortality of schizophrenia

1 reference

12 December 2020

Depression and cardiac mortality: results from a community-based longitudinal study

1 reference

12 December 2020

Depression and subjective quality of life in chronic phase schizophrenic patients.

1 reference

12 December 2020

Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

1 reference

12 December 2020

High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs.

1 reference

12 December 2020

Serum lipids in schizophrenia and other functional psychoses: a general population northern Finland 1966 birth cohort survey

1 reference

12 December 2020

Circulating osteoprotegerin levels are associated with age, waist-to-hip ratio, serum total cholesterol, and low-density lipoprotein cholesterol levels in healthy Korean women.

1 reference

12 December 2020

The metabolic syndrome

1 reference

12 December 2020

Associations between anxiety, depression, and the metabolic syndrome.

1 reference

12 December 2020

Subsyndromal depressive symptoms in middle-aged and older persons with schizophrenia

1 reference

12 December 2020

Depressive symptoms and metabolic syndrome: is inflammation the underlying link?

1 reference

12 December 2020

The capability of plasma osteoprotegerin as a predictor of cardiovascular disease: a systematic literature review

1 reference

12 December 2020

Depression and type 2 diabetes over the lifespan: a meta-analysis

1 reference

12 December 2020

Association between metabolic syndrome and depressive symptoms in middle-aged adults: results from the Whitehall II study

1 reference

12 December 2020

Association of depressive symptoms and metabolic syndrome in men.

1 reference

12 December 2020

Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies

1 reference

12 December 2020

Osteoprotegerin levels in patients with severe mental disorders

1 reference

12 December 2020

Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia.

1 reference

12 December 2020

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

1 reference

12 December 2020

Prevalence of the metabolic syndrome in unipolar major depression

1 reference

12 December 2020

Inflammatory markers in hyperlipidemia: from experimental models to clinical practice.

1 reference

12 December 2020

Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies

1 reference

12 December 2020

Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein

1 reference

12 December 2020

Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors

1 reference

12 December 2020

Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder

1 reference

12 December 2020

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

1 reference

12 December 2020

Prevalence of metabolic syndrome and its association with depression in patients with schizophrenia

1 reference

12 December 2020

Serum levels of fetuin-A, osteoprotegerin and osteopontin in patients with coronary artery disease: effects of statin (HMGCoA-reductase inhibitor) therapy

1 reference

12 December 2020

Excess early mortality in schizophrenia

1 reference

12 December 2020

Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis

1 reference

12 December 2020

Metabolic syndrome, activity of the hypothalamic-pituitary-adrenal axis and inflammatory mediators in depressive disorder

1 reference

12 December 2020

Neuroimmune biomarkers in schizophrenia

1 reference

12 December 2020

Antipsychotics-induced metabolic alterations: focus on adipose tissue and molecular mechanisms

1 reference

12 December 2020

Inflammation, obesity, and metabolic syndrome in depression: analysis of the 2009-2010 National Health and Nutrition Examination Survey (NHANES)

1 reference

12 December 2020

Levels of triglycerides, cholesterol, LDL, HDL and glucose in patients with schizophrenia, unipolar depression and bipolar disorder.

1 reference

12 December 2020

Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis

1 reference

12 December 2020

Inflammatory evidence for the psychosis continuum model

1 reference

12 December 2020

Depression and serum low-density lipoprotein: A systematic review and meta-analysis.

1 reference

12 December 2020

Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study

1 reference

12 December 2020

Low vitamin D is associated with negative and depressive symptoms in psychotic disorders.

1 reference

12 December 2020

Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions

1 reference

12 December 2020

Serum levels of second-generation antipsychotics are associated with cognitive function in psychotic disorders.

1 reference

12 December 2020

Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System

1 reference

12 December 2020

Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies

1 reference

12 December 2020

Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis: A systematic review and meta-analysis.

1 reference

12 December 2020

Increase in serum HDL level is associated with less negative symptoms after one year of antipsychotic treatment in first-episode psychosis.

1 reference

12 December 2020

10.1007/S00406-018-0897-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29721726%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29721726%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference